Concepts (176)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Interleukins | 5 | 2015 | 80 | 0.700 |
Why?
|
| Lymphocytes | 3 | 2016 | 201 | 0.610 |
Why?
|
| Killer Cells, Natural | 3 | 2017 | 217 | 0.600 |
Why?
|
| Orthomyxoviridae Infections | 2 | 2016 | 71 | 0.600 |
Why?
|
| Toxoplasma | 5 | 2013 | 33 | 0.590 |
Why?
|
| Atrioventricular Block | 1 | 2018 | 4 | 0.570 |
Why?
|
| Atrial Flutter | 1 | 2018 | 23 | 0.560 |
Why?
|
| Bradycardia | 1 | 2018 | 33 | 0.560 |
Why?
|
| Lung | 4 | 2020 | 953 | 0.550 |
Why?
|
| Th2 Cells | 2 | 2016 | 98 | 0.530 |
Why?
|
| Haemophilus influenzae | 1 | 2016 | 26 | 0.510 |
Why?
|
| Haemophilus Infections | 1 | 2016 | 13 | 0.510 |
Why?
|
| Lyme Disease | 1 | 2018 | 122 | 0.510 |
Why?
|
| Th1 Cells | 2 | 2016 | 174 | 0.500 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 3 | 2020 | 697 | 0.480 |
Why?
|
| Influenza A virus | 2 | 2016 | 123 | 0.480 |
Why?
|
| Staphylococcus aureus | 1 | 2016 | 176 | 0.460 |
Why?
|
| Staphylococcal Infections | 1 | 2016 | 129 | 0.460 |
Why?
|
| Interleukin-6 | 3 | 2011 | 321 | 0.450 |
Why?
|
| Inflammation Mediators | 2 | 2016 | 176 | 0.440 |
Why?
|
| Electrocardiography | 3 | 2018 | 554 | 0.410 |
Why?
|
| T-Lymphocytes, Helper-Inducer | 3 | 2011 | 113 | 0.380 |
Why?
|
| Cytokine Receptor gp130 | 1 | 2011 | 2 | 0.360 |
Why?
|
| Immunity, Innate | 6 | 2016 | 796 | 0.330 |
Why?
|
| B-Lymphocytes | 3 | 2011 | 574 | 0.310 |
Why?
|
| Electric Injuries | 1 | 2009 | 3 | 0.310 |
Why?
|
| Equipment Failure | 1 | 2009 | 67 | 0.300 |
Why?
|
| Lymphocyte Cooperation | 1 | 2008 | 30 | 0.300 |
Why?
|
| Tachycardia, Atrioventricular Nodal Reentry | 1 | 2008 | 5 | 0.290 |
Why?
|
| T-Lymphocyte Subsets | 2 | 2011 | 248 | 0.280 |
Why?
|
| Toxoplasmosis, Animal | 3 | 2012 | 10 | 0.280 |
Why?
|
| Interleukin-17 | 4 | 2016 | 94 | 0.270 |
Why?
|
| Neoplasms | 1 | 2017 | 1359 | 0.260 |
Why?
|
| Signal Transduction | 5 | 2016 | 3033 | 0.260 |
Why?
|
| Defibrillators, Implantable | 2 | 2014 | 265 | 0.260 |
Why?
|
| Cell Plasticity | 2 | 2016 | 18 | 0.250 |
Why?
|
| Atrial Fibrillation | 3 | 2024 | 837 | 0.230 |
Why?
|
| Cell Differentiation | 6 | 2016 | 1348 | 0.210 |
Why?
|
| Cells, Cultured | 5 | 2016 | 2152 | 0.210 |
Why?
|
| Receptors, Interleukin | 2 | 2015 | 38 | 0.210 |
Why?
|
| Mice, Inbred C57BL | 7 | 2017 | 3391 | 0.200 |
Why?
|
| Vascular Diseases | 1 | 2024 | 81 | 0.200 |
Why?
|
| T-Lymphocytes, Regulatory | 2 | 2017 | 211 | 0.200 |
Why?
|
| Toxoplasmosis | 2 | 2013 | 20 | 0.190 |
Why?
|
| T-Box Domain Proteins | 3 | 2016 | 38 | 0.180 |
Why?
|
| Mice, Knockout | 4 | 2016 | 2107 | 0.180 |
Why?
|
| Mice | 12 | 2017 | 10827 | 0.180 |
Why?
|
| Pulmonary Veins | 1 | 2020 | 38 | 0.170 |
Why?
|
| Animals | 15 | 2017 | 20631 | 0.160 |
Why?
|
| Viruses | 1 | 2020 | 81 | 0.150 |
Why?
|
| Catheter Ablation | 1 | 2020 | 154 | 0.150 |
Why?
|
| Aged | 6 | 2020 | 14385 | 0.150 |
Why?
|
| Ceftriaxone | 1 | 2018 | 19 | 0.140 |
Why?
|
| Bone Marrow Cells | 2 | 2017 | 238 | 0.140 |
Why?
|
| Doxycycline | 1 | 2018 | 46 | 0.140 |
Why?
|
| Gene Expression Regulation | 5 | 2016 | 1617 | 0.140 |
Why?
|
| Humans | 16 | 2024 | 63281 | 0.130 |
Why?
|
| Lymphocyte Activation | 2 | 2011 | 760 | 0.130 |
Why?
|
| Female | 10 | 2020 | 32777 | 0.130 |
Why?
|
| Bacteria | 1 | 2020 | 304 | 0.130 |
Why?
|
| Interferon-gamma | 3 | 2016 | 566 | 0.130 |
Why?
|
| Plasma Cells | 1 | 2017 | 53 | 0.130 |
Why?
|
| Exercise Test | 1 | 2018 | 252 | 0.130 |
Why?
|
| GATA3 Transcription Factor | 1 | 2016 | 16 | 0.130 |
Why?
|
| Antibodies, Protozoan | 2 | 2013 | 52 | 0.120 |
Why?
|
| Bone Marrow | 1 | 2017 | 178 | 0.120 |
Why?
|
| T-Lymphocytes | 2 | 2013 | 1007 | 0.120 |
Why?
|
| Interleukin-12 | 1 | 2016 | 128 | 0.120 |
Why?
|
| Cytokines | 2 | 2016 | 934 | 0.120 |
Why?
|
| Smoke | 1 | 2015 | 24 | 0.120 |
Why?
|
| Diagnosis, Differential | 1 | 2018 | 972 | 0.120 |
Why?
|
| Mice, Inbred CBA | 2 | 2012 | 83 | 0.110 |
Why?
|
| Cardiomyopathy, Hypertrophic | 1 | 2024 | 766 | 0.110 |
Why?
|
| Interleukin-1beta | 1 | 2016 | 264 | 0.110 |
Why?
|
| Echocardiography | 1 | 2018 | 501 | 0.110 |
Why?
|
| Pyroglyphidae | 1 | 2014 | 3 | 0.110 |
Why?
|
| Ventricular Remodeling | 1 | 2014 | 83 | 0.110 |
Why?
|
| Cell Communication | 2 | 2012 | 130 | 0.110 |
Why?
|
| Coronary Sinus | 1 | 2013 | 5 | 0.110 |
Why?
|
| Vascular Fistula | 1 | 2013 | 8 | 0.110 |
Why?
|
| Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2014 | 73 | 0.110 |
Why?
|
| Spleen | 2 | 2012 | 483 | 0.100 |
Why?
|
| Hypersensitivity | 1 | 2014 | 64 | 0.100 |
Why?
|
| Middle Aged | 6 | 2020 | 17541 | 0.100 |
Why?
|
| Salmonella Infections, Animal | 1 | 2012 | 10 | 0.100 |
Why?
|
| Stroke Volume | 1 | 2014 | 332 | 0.100 |
Why?
|
| Lymphotoxin-alpha | 1 | 2012 | 8 | 0.100 |
Why?
|
| Heart Defects, Congenital | 1 | 2013 | 102 | 0.100 |
Why?
|
| Tachycardia, Ventricular | 1 | 2014 | 129 | 0.100 |
Why?
|
| STAT1 Transcription Factor | 2 | 2012 | 34 | 0.090 |
Why?
|
| Phenotype | 1 | 2016 | 1200 | 0.090 |
Why?
|
| Anti-Bacterial Agents | 1 | 2018 | 784 | 0.090 |
Why?
|
| Anti-Arrhythmia Agents | 2 | 2024 | 99 | 0.090 |
Why?
|
| Mice, 129 Strain | 1 | 2011 | 41 | 0.090 |
Why?
|
| CD4-Positive T-Lymphocytes | 2 | 2013 | 641 | 0.090 |
Why?
|
| Mice, Transgenic | 5 | 2015 | 1276 | 0.090 |
Why?
|
| Interleukin-10 | 2 | 2013 | 160 | 0.090 |
Why?
|
| Interleukin-33 | 3 | 2016 | 18 | 0.090 |
Why?
|
| Smoking | 1 | 2016 | 865 | 0.090 |
Why?
|
| Antigen Presentation | 1 | 2011 | 237 | 0.080 |
Why?
|
| Immunoglobulin kappa-Chains | 1 | 2008 | 9 | 0.070 |
Why?
|
| Germinal Center | 1 | 2008 | 40 | 0.070 |
Why?
|
| Dendritic Cells | 1 | 2011 | 524 | 0.070 |
Why?
|
| Peroxidase | 1 | 2008 | 71 | 0.070 |
Why?
|
| Immune Tolerance | 1 | 2008 | 176 | 0.070 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2011 | 718 | 0.070 |
Why?
|
| STAT3 Transcription Factor | 1 | 2007 | 70 | 0.070 |
Why?
|
| Male | 6 | 2020 | 29804 | 0.070 |
Why?
|
| Heart Ventricles | 1 | 2009 | 264 | 0.070 |
Why?
|
| Time Factors | 3 | 2020 | 3759 | 0.060 |
Why?
|
| Problem Solving | 1 | 2006 | 32 | 0.060 |
Why?
|
| Group Processes | 1 | 2006 | 43 | 0.060 |
Why?
|
| Th1-Th2 Balance | 2 | 2016 | 3 | 0.060 |
Why?
|
| Cooperative Behavior | 1 | 2006 | 222 | 0.060 |
Why?
|
| Immunophenotyping | 2 | 2017 | 195 | 0.050 |
Why?
|
| Autoimmunity | 2 | 2017 | 238 | 0.050 |
Why?
|
| United Kingdom | 1 | 2020 | 81 | 0.040 |
Why?
|
| Bacterial Load | 1 | 2020 | 28 | 0.040 |
Why?
|
| Sputum | 1 | 2020 | 37 | 0.040 |
Why?
|
| Europe | 1 | 2020 | 194 | 0.040 |
Why?
|
| Viral Load | 1 | 2020 | 231 | 0.040 |
Why?
|
| Heart Rate | 1 | 2020 | 321 | 0.040 |
Why?
|
| Recurrence | 1 | 2020 | 642 | 0.040 |
Why?
|
| Aged, 80 and over | 2 | 2020 | 5443 | 0.030 |
Why?
|
| United States | 2 | 2020 | 7829 | 0.030 |
Why?
|
| CTLA-4 Antigen | 1 | 2017 | 72 | 0.030 |
Why?
|
| Immunity, Humoral | 1 | 2017 | 40 | 0.030 |
Why?
|
| Quality of Life | 1 | 2024 | 1223 | 0.030 |
Why?
|
| Receptors, Interleukin-12 | 1 | 2016 | 9 | 0.030 |
Why?
|
| Longitudinal Studies | 1 | 2020 | 1254 | 0.030 |
Why?
|
| Inflammation | 2 | 2014 | 1146 | 0.030 |
Why?
|
| Incidence | 1 | 2020 | 1375 | 0.030 |
Why?
|
| Disease Progression | 1 | 2020 | 1168 | 0.030 |
Why?
|
| Interleukin-1 Receptor-Like 1 Protein | 1 | 2015 | 7 | 0.030 |
Why?
|
| Retrospective Studies | 2 | 2020 | 6624 | 0.030 |
Why?
|
| Respiratory Mucosa | 1 | 2015 | 53 | 0.030 |
Why?
|
| Mice, SCID | 1 | 2016 | 520 | 0.030 |
Why?
|
| Alveolar Epithelial Cells | 1 | 2014 | 9 | 0.030 |
Why?
|
| Interleukin-1alpha | 1 | 2014 | 24 | 0.030 |
Why?
|
| Models, Immunological | 1 | 2014 | 85 | 0.030 |
Why?
|
| Macrophages, Alveolar | 1 | 2014 | 64 | 0.030 |
Why?
|
| Receptors, Interleukin-21 | 1 | 2013 | 1 | 0.030 |
Why?
|
| Prospective Studies | 1 | 2020 | 3285 | 0.030 |
Why?
|
| Echocardiography, Transesophageal | 1 | 2013 | 110 | 0.030 |
Why?
|
| Immunity | 1 | 2014 | 107 | 0.030 |
Why?
|
| Heart Atria | 1 | 2013 | 138 | 0.030 |
Why?
|
| Encephalitis | 1 | 2013 | 34 | 0.030 |
Why?
|
| Specific Pathogen-Free Organisms | 1 | 2012 | 42 | 0.020 |
Why?
|
| Weight Loss | 1 | 2015 | 272 | 0.020 |
Why?
|
| Receptors, CXCR3 | 1 | 2012 | 35 | 0.020 |
Why?
|
| Species Specificity | 1 | 2013 | 334 | 0.020 |
Why?
|
| Immunoglobulin M | 1 | 2012 | 115 | 0.020 |
Why?
|
| Mice, Inbred BALB C | 1 | 2014 | 881 | 0.020 |
Why?
|
| Forkhead Transcription Factors | 1 | 2012 | 129 | 0.020 |
Why?
|
| Salmonella typhimurium | 1 | 2012 | 84 | 0.020 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2012 | 297 | 0.020 |
Why?
|
| Protein Subunits | 1 | 2012 | 166 | 0.020 |
Why?
|
| Cell Survival | 1 | 2013 | 569 | 0.020 |
Why?
|
| Adoptive Transfer | 1 | 2011 | 148 | 0.020 |
Why?
|
| Flow Cytometry | 1 | 2012 | 661 | 0.020 |
Why?
|
| Immunoglobulin G | 1 | 2012 | 459 | 0.020 |
Why?
|
| Chronic Disease | 1 | 2013 | 753 | 0.020 |
Why?
|
| Risk Factors | 1 | 2020 | 5338 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2020 | 5649 | 0.020 |
Why?
|
| Macrophages | 1 | 2015 | 1038 | 0.020 |
Why?
|
| Gene Expression Profiling | 1 | 2012 | 771 | 0.020 |
Why?
|
| Cell Count | 1 | 2008 | 130 | 0.020 |
Why?
|
| Homeodomain Proteins | 1 | 2010 | 266 | 0.020 |
Why?
|
| Acute Disease | 1 | 2010 | 672 | 0.020 |
Why?
|
| Antibodies | 1 | 2008 | 182 | 0.020 |
Why?
|
| Illinois | 1 | 2006 | 13 | 0.020 |
Why?
|
| Autoimmune Diseases | 1 | 2008 | 230 | 0.020 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2013 | 1618 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2006 | 608 | 0.010 |
Why?
|
| Brain | 1 | 2013 | 1555 | 0.010 |
Why?
|
| Apoptosis | 1 | 2008 | 1073 | 0.010 |
Why?
|